Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First-Line Therapy in Patients With Metastatic Triple-Negative Breast Cancer in ASCENT-03 ...

Gilead Sciences, Inc. (Nasdaq: GILD) today shared positive data from the Phase 3 ASCENT-03 study demonstrating a highly statistically significant and clinically meaningful improvement in ...

UK Government unveils plan to ‘train up next generation of clean energy workers’

At the same time, the Scottish Government said it would fund, alongside Westminster, an £18 million fund to help workers ...

How Recent Developments Are Shaping the Hagerty Growth Story According to Wall Street Analysts

Hagerty’s Fair Value Estimate has been raised slightly from $13.17 to $13.29 per share, following a recent mix of optimism and caution among market analysts. While the revenue growth projection has ...